Cortisol And PTSD Research

A comprehensive guide to the latest findings on cortisol, trauma, and the stress response

---

Table of Contents

• What Is Cortisol and Why Does It Matter in Trauma?
• The HPA Axis and PTSD: Understanding the Stress System
• Does PTSD Cause High or Low Cortisol?
• Key Research Findings: What the Studies Show
• Why Are Cortisol Findings in PTSD So Inconsistent?
• Cortisol Patterns Across Different Times of Day
• How Trauma Type, Sex, and Age Affect Cortisol
• Cortisol and Fear Learning: The 2025 Research Update
• Depression, Neuroticism, and Dissociation: Complicating Factors
• Can Cortisol Predict Who Will Develop PTSD?
• Cortisol as a Treatment Target in PTSD
• Saliva vs. Blood Cortisol: Which Matters More?
• Children, Cortisol, and Trauma
• What the Research Means for Clinicians and Survivors
• Summary and Key Takeaways

---

Introduction

When a person experiences something traumatic — a car accident, sexual violence, combat, or childhood abuse — the body's stress response activates immediately. Hormones flood the bloodstream. Heart rate climbs. The brain shifts into survival mode. Among all the biological players involved in this cascade, cortisol has attracted more scientific attention than perhaps any other.

For decades, researchers studying cortisol and PTSD research have asked the same fundamental questions: Does trauma permanently alter the body's cortisol system? Can a blood test or saliva sample tell us who is at risk for post-traumatic stress disorder? And could manipulating cortisol levels one day become a genuine treatment option?

The answers are far more complicated — and far more fascinating — than early researchers hoped. This post breaks down what the evidence actually shows, why the findings are often contradictory, and where the science is heading in 2025 and beyond.

---

---

What Is Cortisol and Why Does It Matter in Trauma?

Cortisol is a glucocorticoid steroid hormone produced by the adrenal cortex, the outer layer of the adrenal glands that sit just above the kidneys. It is often called the "stress hormone," though this label undersells its complexity. Cortisol serves critical roles in:

• Regulating metabolism — controlling how the body uses fats, proteins, and carbohydrates
• Managing inflammation — acting as a natural anti-inflammatory signal
• Controlling blood pressure and blood sugar
• Regulating the sleep-wake cycle — cortisol naturally peaks in the early morning and declines through the day
• Modulating memory consolidation — particularly for emotionally significant events

Under stress, cortisol levels rise sharply. This is adaptive in the short term: the hormone mobilizes energy, sharpens alertness, and helps the body respond to threats. But when the stress response becomes dysregulated — as often happens after severe or repeated trauma — the cortisol system may never fully reset.

Understanding cortisol trauma responses requires recognizing that cortisol does not work in isolation. It is the end product of a sophisticated hormonal cascade that begins in the brain itself.

---

The HPA Axis and PTSD: Understanding the Stress System

The hypothalamic-pituitary-adrenal (HPA) axis is the central stress-response system of the body, and it lies at the heart of nearly all cortisol PTSD research.

Here is how the system works under normal conditions:

1. The hypothalamus detects a stressor and releases corticotropin-releasing hormone (CRH).
2. CRH travels to the pituitary gland, which responds by secreting adrenocorticotropic hormone (ACTH).
3. ACTH travels through the bloodstream to the adrenal glands, stimulating the release of cortisol.
4. Cortisol feeds back to the hypothalamus and pituitary, suppressing further CRH and ACTH release in what is called negative feedback.

This elegant feedback loop keeps stress responses proportionate and time-limited. In people with PTSD, however, this loop appears to malfunction. The stress disorder HPA axis can become either oversensitive or undersensitive depending on the individual, the trauma type, and a range of genetic and environmental factors.

A landmark 2024 review published in PMC titled Post Traumatic Stress Disorder Associated Hypothalamic-Pituitary-Adrenal Axis Dysfunction and Glucocorticoid Receptor Signaling provided a detailed account of how PTSD HPA axis disruptions manifest at the molecular level. The review highlighted not just altered cortisol levels but changes in glucocorticoid receptors (GRs) — the proteins that cortisol actually binds to in order to produce its effects. Even when cortisol levels appear normal, receptor sensitivity can be dramatically altered, meaning that standard cortisol measurements may not tell the full story.

Key points about HPA-PTSD dysfunction:

• CRH dysregulation: Many PTSD patients show elevated CRH in cerebrospinal fluid, suggesting the upstream signaling is hyperactive even when downstream cortisol appears low.
• Glucocorticoid receptor hypersensitivity: Enhanced GR sensitivity in PTSD may cause the system to suppress cortisol production too aggressively, contributing to the low cortisol patterns seen in some patients.
• ACTH-cortisol dissociation: Some HPA PTSD research shows that ACTH and cortisol levels do not track together as expected, pointing to a functional disconnect within the axis.

Understanding trauma cortisol dysregulation at this systems level is essential before diving into the clinical research, because it explains why measuring cortisol alone — without considering receptor function, feedback sensitivity, or upstream hormone levels — gives only a partial picture.

---

Does PTSD Cause High or Low Cortisol?

This is the question most people start with, and the honest answer is: it depends.

Early PTSD research in the 1980s and 1990s produced a surprising finding. Researchers had expected trauma survivors to show elevated cortisol — after all, they were under chronic stress. Instead, several landmark studies found that combat veterans and Holocaust survivors with PTSD had lower cortisol than healthy controls or trauma-exposed individuals without PTSD.

This finding was counterintuitive and controversial. How could people who were clearly stressed have less cortisol?

Several explanations were proposed:

• Enhanced negative feedback: The HPA axis in PTSD may become hypersensitive to cortisol's inhibitory signals, switching off production too quickly and too completely.
• Adrenal fatigue or exhaustion: After prolonged stress, the adrenal glands may produce less cortisol.
• Epigenetic changes: Trauma, particularly early-life trauma, may produce lasting changes in gene expression that reduce cortisol output.
• Adaptation, not deficiency: Some researchers argue that low cortisol in PTSD represents a form of adaptive downregulation, not pathology.

But the low-cortisol hypothesis has never been universally confirmed. Subsequent research has found high cortisol in some PTSD populations, and no significant difference in others. A 2024 review summarizing 17 studies on PTSD cortisol found:

• 9 studies reported decreased cortisol in PTSD
• 6 studies found no significant difference
• 1 study found elevated cortisol
• 1 study reported mixed results

This heterogeneity is not a failure of the science — it is a signal that cortisol stress disorder relationships are mediated by dozens of variables that most individual studies do not fully control for.

---

Key Research Findings: What the Studies Show

To make sense of the field, it helps to look at the largest and most rigorous studies available.

The 2008 Meta-Analysis: A Landmark Null Finding

One of the most cited papers in this field is a systematic review and meta-analysis published on PubMed examining cortisol and post-traumatic stress disorder in adults. Drawing on 37 studies with 828 individuals with PTSD and 800 controls, this PTSD cortisol study reached a surprising conclusion: across all studies combined, overall cortisol levels did not differ significantly between people with PTSD and controls. The pooled standardized mean difference (SMD) was just -0.12 (95% CI: -0.32 to 0.08) — a small, statistically non-significant effect.

However — and this is crucial — the meta-analysis also found important moderating effects:

• Lower cortisol was found in plasma or serum samples compared to urine or saliva
• Studies including more females tended to show lower cortisol in PTSD
• Physical or sexual abuse samples showed more pronounced cortisol reductions
• Afternoon sampling was associated with lower cortisol compared to morning sampling

This means that the "null finding" was actually concealing real effects that only emerged when researchers looked at specific subgroups and methodological conditions. The absence of a universal cortisol signature in PTSD does not mean cortisol is irrelevant — it means the relationship is conditional.

The 2012 Meta-Analysis: Daily Output Matters

A larger meta-analysis examining 47 studies with 6,008 individuals took a different approach, focusing on daily cortisol output rather than single-point measurements. This cortisol PTSD study found:

• People with PTSD showed lower daily cortisol output compared to no-trauma controls, with an effect size of d = -0.36
• People with PTSD plus comorbid major depressive disorder (MDD) showed even lower daily output, with d = -0.65
• The PTSD-only group had significantly lower cortisol than trauma-exposed individuals who did not develop PTSD

This suggests that the cortisol reduction in PTSD is real and measurable when you look at the full diurnal cycle rather than a snapshot. The additional suppression seen with comorbid depression raises important questions about how mood disorders interact with the HPA system in trauma survivors.

The 2024 Longitudinal Study: Cortisol-Neuroticism Interaction

A particularly well-designed cortisol PTSD study published in 2024 followed 923 injured patients over two years to identify who would develop PTSD after physical injury. Of those patients, 112 (12.1%) developed PTSD at some point during follow-up. The prevalence peaked early and then declined — from 8.8% at 3 months to 3.7% at 24 months.

The key finding about cortisol was nuanced: serum cortisol alone did not directly predict PTSD development. However, there was a significant interaction effect: lower cortisol combined with higher neuroticism significantly increased PTSD risk in the early post-injury period.

This interaction effect is important because it suggests that cortisol does not operate in isolation. Psychological traits — particularly the tendency toward negative emotional reactivity represented by neuroticism — may amplify or dampen the effects of cortisol dysregulation on PTSD risk.

---

---

Why Are Cortisol Findings in PTSD So Inconsistent?

If you read the scientific literature on PTSD cortisol patterns, you will quickly notice that the findings seem to contradict each other. One study finds low cortisol, another finds no difference, a third finds elevated cortisol. Why?

This inconsistency is not random. It reflects genuine complexity in the biology and methodology of this research area. Here are the major sources of variability:

1. Measurement Method and Sample Type

Cortisol can be measured in:

• Blood (serum or plasma) — reflects cortisol at a single moment in time
• Saliva — easier to collect, non-invasive, reflects free (unbound) cortisol
• Urine (24-hour) — reflects total cortisol output over a day
• Hair — reflects cumulative cortisol over weeks or months

Each method captures something different. The 2008 meta-analysis found that plasma/serum samples showed lower cortisol in PTSD while other methods did not produce the same effect. Studies that mix these measurement types will inevitably produce inconsistent results.

2. Time of Sample Collection

Cortisol follows a diurnal rhythm — it is highest in the early morning (the cortisol awakening response, or CAR) and lowest in the late evening. Disruptions to this rhythm, rather than changes in absolute level, may be the most relevant feature of PTSD cortisol patterns. A study collecting samples only in the morning will see something different from one collecting samples in the afternoon or evening.

3. Population Heterogeneity

PTSD is not a single, uniform condition. Research participants differ in:

• Type of trauma (combat, childhood abuse, sexual assault, accidents, natural disasters)
• Time since trauma (acute vs. chronic PTSD)
• Severity of symptoms
• Comorbid conditions (depression, anxiety, substance use)
• Sex and hormonal status (pre- vs. post-menopausal women; testosterone in men)
• Age at trauma exposure (developmental timing matters enormously)

4. Control Group Differences

Studies vary in whether they compare PTSD patients to:

• Healthy controls with no trauma exposure
• Trauma-exposed individuals without PTSD
• Individuals with other anxiety disorders or depression

Each comparison answers a different question. Comparing PTSD to non-trauma controls conflates the effects of trauma exposure with the effects of PTSD specifically.

5. Small Sample Sizes and Publication Bias

Many studies in this field have relatively small samples, which reduces statistical power and increases the risk of false positives. Publication bias — the tendency for studies with positive or significant findings to be published more readily than null findings — may also skew the apparent consensus.

Understanding these sources of inconsistency is not just methodologically important. It explains why trauma cortisol dysregulation cannot be fully captured by a single biomarker test and why research must continue to adopt more sophisticated, multivariate approaches.

---

Cortisol Patterns Across Different Times of Day

One of the most important insights in PTSD cortisol research is that when cortisol is measured matters enormously. The diurnal cortisol rhythm in PTSD may be altered in ways that single-point measurements miss entirely.

The Cortisol Awakening Response (CAR)

The CAR refers to the sharp rise in cortisol that occurs within 30–45 minutes of waking. In healthy individuals, this morning surge is robust and consistent. In PTSD, several studies have found that the CAR is blunted or attenuated, meaning the morning peak is smaller than expected.

A blunted CAR is thought to reflect reduced HPA axis reactivity or impaired anticipatory stress response. It has been linked to burnout, chronic stress, and other conditions characterized by prolonged stress exposure — making it a plausible marker of trauma cortisol dysregulation.

The Diurnal Slope

Beyond the morning peak, cortisol PTSD research has also examined the slope of cortisol decline across the day. In healthy individuals, cortisol drops steadily from morning to evening. Some studies in PTSD populations show a flatter diurnal slope — meaning cortisol levels stay relatively elevated through the day rather than declining normally. This pattern is associated with poor health outcomes including inflammation and metabolic dysfunction.

Evening and Nighttime Cortisol

The 2008 meta-analysis specifically noted that afternoon sampling was more likely to reveal lower cortisol in PTSD patients, whereas morning samples showed less consistent effects. This suggests that the normal afternoon/evening decline in cortisol may be accelerated or exaggerated in some PTSD patients — dropping to abnormally low levels by mid-to-late day.

Cortisol and Sleep

Given that PTSD commonly involves sleep disturbances including nightmares and insomnia, it is not surprising that nighttime cortisol patterns are also disrupted. Some research suggests that PTSD patients show elevated cortisol during sleep — particularly during REM sleep stages associated with dreaming — which may contribute to the hyperarousal and nightmare symptoms characteristic of the disorder.

These PTSD cortisol patterns across the day underscore why a single morning blood draw cannot capture the full picture of HPA dysregulation in trauma survivors.

---

How Trauma Type, Sex, and Age Affect Cortisol

One of the clearest lessons from the last two decades of PTSD cortisol research is that the cortisol-PTSD relationship is not uniform across all people and all traumas. Key moderating variables include:

Trauma Type

The 2008 meta-analysis found that physical or sexual abuse was associated with more pronounced cortisol reductions in PTSD compared to other trauma types such as combat exposure or accidents. This makes biological sense: interpersonal violence, particularly when it is repeated and occurs in relationships of trust or dependency, tends to produce more pervasive disruptions to stress-response systems than single-incident traumas.

Childhood trauma deserves special mention. Early adverse experiences appear to produce particularly lasting changes in HPA PTSD function, potentially through epigenetic mechanisms — alterations in gene expression that do not change the underlying DNA sequence but can persist across decades or even generations. Children exposed to chronic abuse or neglect may show altered cortisol reactivity that persists into adulthood, increasing vulnerability to mood and anxiety disorders.

Sex Differences

Biological sex is one of the most significant moderators of cortisol PTSD relationships, yet it is often inadequately addressed in research studies. The 2008 meta-analysis found that studies with higher proportions of female participants showed more pronounced cortisol reductions in PTSD.

Several factors may explain sex differences:

• Gonadal hormones: Estrogen modulates HPA axis reactivity, meaning cortisol responses differ across the menstrual cycle, during pregnancy, and after menopause.
• Differences in trauma type: Women are more likely to experience sexual and interpersonal violence, which may produce different cortisol profiles than combat trauma more common in male study populations.
• Differential HPA sensitivity: Some evidence suggests females have inherently higher HPA axis reactivity than males, which could translate into more pronounced dysregulation after trauma.

Age at Trauma Exposure

Trauma experienced during critical developmental windows — particularly early childhood and adolescence — appears to produce more lasting HPA axis changes than trauma first experienced in adulthood. The brain and stress-response systems are more plastic during development, meaning disruptions at these stages can produce enduring structural and functional changes.

Age at the time of the study also matters. Older trauma survivors may show different cortisol stress disorder profiles than younger individuals due to the natural age-related decline in HPA axis function and cortisol levels.

Chronicity and Cumulative Trauma

People who experience a single traumatic event differ from those with repeated or ongoing trauma. Cumulative trauma exposure — multiple adverse events across the lifespan — is associated with more severe PTSD symptoms and more pronounced HPA dysregulation. Individuals with complex PTSD (which involves prolonged, repeated interpersonal trauma) may show different PTSD cortisol patterns than those with classic single-incident PTSD.

---

Cortisol and Fear Learning: The 2025 Research Update

One of the most exciting areas of cortisol and PTSD research in recent years focuses not on cortisol levels per se but on how cortisol influences the learning and unlearning of fear — a process directly relevant to understanding why PTSD symptoms persist.

A 2025 review published in PMC titled Cortisol Imbalance and Fear Learning in PTSD provided a comprehensive account of how cortisol PTSD interactions shape fear memory formation and extinction.

Fear Acquisition and Cortisol

When a traumatic event occurs, elevated cortisol interacts with the amygdala — the brain's threat-detection center — to consolidate fear memories. Cortisol enhances the laying down of strong, emotionally salient memories, which is adaptive when those memories serve as warnings against future danger.

However, in PTSD, this memory consolidation process appears to become dysregulated. Memories of the traumatic event may be encoded with excessive emotional intensity and insufficient contextual information, making them difficult to distinguish from present-moment threats. The result is the intrusive recollections, flashbacks, and hyperreactivity that define PTSD.

Fear Extinction and Cortisol

Perhaps more important for understanding PTSD is cortisol's role in fear extinction — the process by which fear memories are dampened through repeated safe exposure to fear cues without negative consequences. Fear extinction is the biological basis of exposure-based therapies for PTSD.

The 2025 review highlighted that cortisol dysregulation is linked to impaired fear extinction and altered glucocorticoid signaling in PTSD. Specifically:

• Insufficient cortisol during extinction may impair the consolidation of "safety memories" that compete with fear memories
• Glucocorticoid receptor dysfunction may mean that cortisol signals are not effectively translated into fear extinction even when cortisol levels are adequate
• The timing of cortisol availability relative to fear extinction learning may be critical — cortisol's effects on memory are highly time-dependent

Implications for Treatment

This understanding of trauma cortisol dysregulation in fear learning has direct therapeutic implications. Some researchers have investigated whether administering cortisol (or synthetic glucocorticoids like hydrocortisone) before or after extinction-based therapy could enhance fear memory erasure.

Preliminary evidence is intriguing: several small studies have found that hydrocortisone administration can facilitate fear extinction in healthy subjects and reduce PTSD symptoms in clinical samples. We will return to this in the section on cortisol as a treatment target.

---

Depression, Neuroticism, and Dissociation: Complicating Factors

Interpreting cortisol PTSD research is further complicated by the fact that PTSD rarely occurs in isolation. The presence of comorbid conditions and personality characteristics substantially alters cortisol profiles.

Major Depressive Disorder (MDD)

Depression and PTSD co-occur in a large proportion of patients — estimates range from 30% to 50% or higher. Interestingly, while PTSD alone tends to be associated with lower cortisol, depression alone is often associated with higher cortisol due to HPA axis hyperactivation.

The 2012 meta-analysis found that PTSD plus comorbid MDD was associated with even lower cortisol output (d = -0.65) compared to PTSD alone (d = -0.36). This suggests that the two conditions do not simply combine their cortisol effects; rather, their co-occurrence may produce a distinct HPA profile that is more severely suppressed than either condition alone.

Neuroticism

The 2024 longitudinal study introduced neuroticism — a personality trait characterized by emotional instability and a tendency toward negative affect — as an important moderator of the cortisol-PTSD relationship. Specifically, the interaction between lower cortisol and higher neuroticism significantly increased PTSD risk following injury.

This interaction effect suggests that cortisol does not operate as a simple, universal biomarker of PTSD risk. Its significance depends on the psychological context in which it occurs. People who are already prone to negative emotional reactivity may be more vulnerable to the consequences of low cortisol availability after trauma.

Dissociation

A 2025 study published in the Clinical Psychopharmacology and Neuroscience (CPN) journal examined the relationship between dissociative symptoms and morning cortisol in PTSD patients. The study found a negative correlation between dissociation and morning serum cortisol — meaning that patients with higher levels of dissociative symptoms tended to have lower morning cortisol.

Dissociation — the experience of detachment from one's thoughts, feelings, body, or surroundings — is thought to represent a distinct pathological subtype of PTSD characterized by emotional numbing and depersonalization/derealization rather than hyperarousal. The finding that dissociative PTSD is associated with particularly low morning cortisol adds nuance to PTSD cortisol patterns, suggesting that the cortisol profile may differ between hyperarousal-dominant and dissociation-dominant subtypes.

Substance Use

Alcohol and drug use disorders are common comorbidities in PTSD and are known to independently affect HPA axis function. Alcohol, in particular, can both elevate and suppress cortisol depending on the pattern of use. Studies that do not adequately screen for or control substance use comorbidities may produce misleading cortisol stress disorder findings.

---

---

Can Cortisol Predict Who Will Develop PTSD?

One of the most practical and clinically significant questions in PTSD cortisol research is whether cortisol measured shortly after a traumatic event can predict who will go on to develop PTSD.

The appeal of a predictive biomarker is obvious: if clinicians could identify high-risk individuals in emergency departments and trauma units, they could target early interventions where they are most needed.

The Early Evidence

Early prospective studies suggested that lower cortisol in the immediate aftermath of trauma was associated with higher PTSD risk. Studies of motor vehicle accident survivors and assault victims found that those who later developed PTSD tended to have lower cortisol in emergency department blood draws than those who recovered without PTSD.

This finding fit neatly with the low-cortisol model of PTSD: insufficient cortisol response to trauma might impair the normal processes of stress recovery, emotional regulation, and fear extinction consolidation.

The 2024 Longitudinal Data

The 2024 study following 923 injured patients over two years provides the most rigorous recent test of this hypothesis. Its finding was sobering: cortisol alone did not significantly predict PTSD development. Only when combined with high neuroticism did low cortisol emerge as a meaningful risk indicator.

This suggests that cortisol is probably not useful as a standalone predictive biomarker. Its predictive value appears to be conditional — dependent on psychological characteristics that modify its biological impact.

Cortisol Response, Not Just Level

A growing body of research suggests that the reactivity of the cortisol response to stress — how much cortisol rises in response to a standardized challenge — may be more informative than baseline levels. The dexamethasone suppression test (DST), which examines how strongly the HPA axis responds to synthetic glucocorticoid, has revealed enhanced suppression in many PTSD patients — consistent with hypersensitive negative feedback.

Reactivity measures add a dynamic dimension to PTSD cortisol research that static level measurements cannot capture.

Cortisol Response to Traumatic Stress as a Predictor

A PMC-indexed study specifically examining cortisol response to traumatic stress as a predictor of PTSD symptom development found that cortisol did not predict overall PTSD symptoms but showed some associations with emotion-related state measures. This nuanced finding aligns with the emerging view that cortisol's relevance in PTSD may be more symptom-specific than syndrome-wide — affecting particular aspects of emotional processing rather than the full diagnostic picture.

---

Cortisol as a Treatment Target in PTSD

Understanding cortisol PTSD biology opens the door to potential treatment applications. If cortisol dysregulation contributes to PTSD symptoms and impaired recovery, could correcting that dysregulation form the basis of new therapies?

Hydrocortisone Administration

The most direct approach is to administer cortisol itself in the form of hydrocortisone. Several lines of evidence support this approach:

Immediately post-trauma: Some research has investigated whether hydrocortisone given in the acute post-trauma period (such as during intensive care for surgical patients or burns patients) could prevent PTSD development. Results have been mixed but encouraging in some populations, particularly ICU patients, where steroid treatment appeared to reduce later PTSD incidence.

Enhancing exposure therapy: The fear extinction research discussed earlier suggests that cortisol may enhance the consolidation of extinction memories. Studies have explored whether taking hydrocortisone before trauma-focused therapy sessions could boost treatment outcomes. Early trials have shown promising effects, particularly for augmenting extinction-based therapies such as prolonged exposure.

Timing is everything: Cortisol's effects on memory are acutely time-dependent. The same hormone that consolidates fear memories shortly after trauma may help extinguish them if given during a later extinction learning period. Optimal timing of any cortisol-based intervention is a critical and still partially unresolved question.

Targeting the Glucocorticoid Receptor

Given the 2024 review's findings on PTSD HPA axis dysfunction at the receptor level, some researchers are exploring drugs that modify glucocorticoid receptor function directly rather than simply raising or lowering cortisol levels. If the problem is hypersensitive receptor signaling rather than hormone deficiency, then receptor modulators — rather than cortisol itself — may be the more appropriate therapeutic target.

CRH Antagonists

Since many PTSD patients show elevated CRH despite low peripheral cortisol, targeting the upstream CRH signal is another strategy. CRH1 receptor antagonists have shown promise in animal models of PTSD and in early human studies for anxiety and depression. Their potential in PTSD specifically remains an active area of investigation.

DHEA and Cortisol Balance

Dehydroepiandrosterone (DHEA) is another adrenal hormone that often sits in balance with cortisol. Some stress disorder HPA research has found that PTSD patients show an unfavorable cortisol-to-DHEA ratio, with relatively more cortisol relative to the protective effects of DHEA. DHEA supplementation has been explored as a way to restore this balance, though evidence from clinical trials remains preliminary.

Lifestyle and Behavioral Approaches

Cortisol levels are sensitive to a range of lifestyle factors that are already relevant to PTSD treatment:

• Exercise: Regular aerobic exercise reduces baseline cortisol and improves HPA axis regulation
• Sleep improvement: Treating sleep disturbances in PTSD may help normalize the diurnal cortisol rhythm
• Mindfulness and meditation: These practices have been shown to reduce cortisol responses to stress
• Social support: Strong social connections buffer HPA axis reactivity

These approaches do not target cortisol directly but may contribute to normalizing HPA PTSD function as part of comprehensive trauma-focused care.

---

Saliva vs. Blood Cortisol: Which Matters More?

A practical question for both researchers and clinicians is which sample type provides the most meaningful information in the context of cortisol PTSD research.

Blood Cortisol

Serum or plasma cortisol measures total cortisol — both bound (to cortisol-binding globulin and albumin) and free. However, only free cortisol is biologically active. About 90-95% of blood cortisol is bound, meaning that serum measurements may not accurately reflect the physiologically relevant free fraction.

Blood collection also has practical limitations: it requires venipuncture, which is itself a minor stressor that can influence cortisol levels. The stress of the collection procedure may confound results, particularly in PTSD patients who may have elevated anxiety in medical settings.

Saliva Cortisol

Salivary cortisol reflects free, unbound cortisol — the biologically active fraction — without the bound component. This makes it a more direct measure of physiologically relevant cortisol. Saliva collection is also non-invasive, can be done at home, and can easily be repeated across multiple time points throughout the day — making it ideal for capturing PTSD cortisol patterns across the diurnal cycle.

The 2008 meta-analysis found that plasma/serum samples showed lower cortisol in PTSD compared to controls, while other sample types showed less consistent effects. This may reflect methodological differences in what each measure captures rather than a true biological distinction.

Urine Cortisol

Twenty-four-hour urinary free cortisol provides an integrated measure of cortisol output across an entire day. It is less susceptible to the noise of individual time-point measurements and captures the full diurnal pattern. However, it requires accurate 24-hour urine collection, which can be difficult to achieve in research and clinical settings.

Hair Cortisol

An emerging approach uses hair cortisol concentrations to reflect cumulative cortisol exposure over weeks to months. A centimeter of hair represents approximately one month of cortisol history. Hair cortisol has attracted interest in PTSD cortisol research because it captures long-term HPA activity rather than moment-to-moment fluctuations. However, it is affected by hair treatments, ethnicity, and other factors that complicate interpretation.

The Verdict

For research purposes, the gold standard is likely a combination of approaches: salivary samples collected at multiple time points throughout the day (to capture the CAR and diurnal slope) supplemented by 24-hour urinary free cortisol for total output estimates. Single-point blood draws, while convenient, provide the least informative snapshot of trauma cortisol dysregulation.

---

Children, Cortisol, and Trauma

Developmental considerations add another layer of complexity to cortisol and PTSD research. The cortisol system in children is fundamentally different from that in adults, and the consequences of trauma on HPA function may depend critically on the developmental stage at which exposure occurs.

2024 Research on Children

A 2024 study on children's responses to trauma, examining cortisol and PTSD in a pediatric population, found no significant cortisol differences across times or samples and highlighted the heterogeneity in the field. This null finding in children mirrors the mixed results seen across adult studies and suggests that the same methodological and population-level variables that complicate adult research apply equally — perhaps more acutely — in pediatric samples.

Why Children Are Different

Several features of child development complicate cortisol-PTSD research:

• Developmental HPA trajectories: Cortisol levels and diurnal rhythms change substantially across childhood and adolescence, making it challenging to establish normative baselines.
• Stress reactivity in early life: Infants and young children show different cortisol responses to stress than older children and adults. The familiar U-shaped relationship between stress intensity and cortisol response may look different at different developmental stages.
• The influence of caregiver relationships: In children, the stress-response system is co-regulated by caregivers. Trauma that disrupts primary attachment relationships — such as abuse by parents — may affect HPA development through mechanisms very different from those operating in adult trauma.
• Adverse Childhood Experiences (ACEs): Research on ACEs has demonstrated that childhood adversity produces lasting changes in PTSD HPA axis function that increase vulnerability to mental and physical illness across the lifespan. The dose-response relationship between ACEs and health outcomes underscores the biological embedding of early stress.

Long-Term Consequences

Childhood trauma-related trauma cortisol dysregulation may not manifest immediately but can produce measurable HPA alterations that persist for decades. Adults presenting with PTSD following adult-onset trauma may have pre-existing cortisol vulnerabilities rooted in adverse childhood experiences — a factor that is rarely adequately controlled in adult PTSD research.

---

What the Research Means for Clinicians and Survivors

After reviewing this body of evidence, what practical lessons can be drawn for those working with trauma survivors — or for survivors themselves trying to understand their own biology?

For Clinicians

1. Cortisol is not a diagnostic biomarker for PTSD. The research does not support using a single cortisol test to diagnose PTSD or rule it out. The relationship between cortisol stress disorder and symptom severity is too variable and context-dependent for this application.

2. Cortisol patterns may inform subtype identification. The association of low morning cortisol with dissociative symptoms, and the different patterns seen with PTSD-plus-depression versus PTSD alone, suggests that PTSD cortisol patterns may help characterize clinically meaningful subtypes that respond differently to treatment. Incorporating HPA markers into clinical assessment frameworks may eventually improve treatment matching.

3. Comorbidity profoundly affects cortisol. Clinicians should be aware that the presence of depression, dissociation, substance use, or high neuroticism substantially alters the cortisol picture. Interpreting any cortisol findings in PTSD patients requires a full clinical picture.

4. Treatment approaches targeting HPA function show promise. While no cortisol-based treatment is yet standard of care for PTSD, the emerging evidence for hydrocortisone augmentation of exposure therapy is worth monitoring. Clinicians using trauma-focused cognitive behavioral therapy or prolonged exposure may be working with patients whose HPA function could benefit from adjunctive biological support.

5. Lifestyle interventions matter. Sleep, exercise, and social support all influence HPA PTSD function and should be explicitly incorporated into treatment planning for trauma survivors, not treated as optional lifestyle add-ons.

For Trauma Survivors

If you have PTSD or are recovering from trauma and have read about cortisol research, a few points are worth emphasizing:

Your biology has been changed by what happened to you. The research on cortisol trauma dysregulation confirms what many trauma survivors intuitively know: their bodies respond differently to stress now. This is not weakness or imagination — it is a measurable biological reality.

Low cortisol is not something to "fix" with supplements. The cortisol changes seen in PTSD are part of a complex system-level dysregulation. Simply taking cortisol supplements is not advisable without medical supervision and would not address the underlying HPA dysregulation.

Your cortisol profile may be different from someone else's with PTSD. The research makes clear that cortisol PTSD patterns vary enormously based on trauma type, gender, age, comorbidities, and many other factors. Do not assume that your experience of PTSD is biologically identical to anyone else's.

Evidence-based treatments work, in part, by normalizing stress biology. Trauma-focused therapies such as EMDR, Prolonged Exposure, and Cognitive Processing Therapy have been shown to reduce PTSD symptoms. The biological changes underlying recovery likely include normalization of HPA axis function — providing an additional reason to engage with evidence-based treatment.

---

Summary and Key Takeaways

The field of cortisol and PTSD research is one of the most active and important areas of trauma biology. Here is what the current evidence tells us:

What We Know With Confidence

• The HPA PTSD axis is dysregulated in many trauma survivors, but the pattern of dysregulation is not uniform.
• Daily cortisol output tends to be lower in PTSD compared to both trauma-exposed controls and no-trauma controls, with moderate effect sizes, but individual studies show enormous variability.
• Cortisol's role in fear learning and extinction is increasingly well understood; cortisol facilitates both fear memory consolidation and extinction learning, with dysregulated glucocorticoid signaling impairing the latter.
• Moderating variables — including trauma type, sex, age at trauma, sample collection method, time of day, and psychiatric comorbidities — explain much of the inconsistency in the literature.
• Neuroticism interacts with low cortisol to increase PTSD risk after injury, suggesting that personality and biology must be considered together.
• Dissociative PTSD may be characterized by particularly low morning cortisol, pointing to biologically distinct PTSD subtypes.

What Remains Uncertain

• Whether any cortisol measure can serve as a reliable predictive biomarker for PTSD development
• The precise mechanisms linking glucocorticoid receptor hypersensitivity to symptom expression
• The optimal timing, dose, and population for cortisol-augmented therapy
• How childhood cortisol dysregulation translates into adult PTSD vulnerability

Where the Field Is Heading

The 2024 and 2025 research reviewed here reflects a field moving toward greater nuance and precision. Rather than asking "does PTSD cause high or low cortisol?" the most productive research is now asking: "Under what conditions, in which people, measured in which ways, does cortisol dysregulation contribute to which specific aspects of post-traumatic psychopathology?"

The answers to those more precise questions will ultimately produce better diagnostics, better risk stratification, and better treatments for the hundreds of millions of people around the world living with the consequences of trauma.

---

---

References and Sources

1. Meewisse M-L, et al. (2007). Cortisol and post-traumatic stress disorder in adults. British Journal of Psychiatry. PubMed: 17978317.
2. Morris MC, Compas BE, Garber J. (2012). Relations among posttraumatic stress disorder, comorbid major depression, and HPA function. Cited in PMC meta-analysis.
3. PMC Review [2024]. Post traumatic stress disorder associated hypothalamic-pituitary-adrenal axis dysfunction and glucocorticoid receptor signaling. PMC11401111.
4. PMC Review [2025]. Cortisol Imbalance and Fear Learning in PTSD. PMC12163469.
5. PubMed Study [2024]. Serum cortisol and neuroticism for post-traumatic stress disorder development in injured patients over 2 years.
6. UEA ePrints [2024]. Children's responses to trauma: a study of cortisol and PTSD.
7. CPN Journal [2025]. Association between Dissociative Symptoms and Morning Cortisol in PTSD patients.
8. PMC [2023–2026]. Cortisol response to traumatic stress to predict PTSD symptom development.

---

This article is intended for educational and informational purposes. It does not constitute medical advice. If you or someone you know is experiencing symptoms of PTSD, please consult a qualified mental health professional.